The concentration (i.e., Semaglutide 2.5 mg/mL)
Diaz Vivancos P, Wolff T, Markovic J, Pallard FV, Foyer CH
Additionally, evaluating the long-term use of GLP-1RA, particularly across different populations, could provide valuable insights into its therapeutic potential and risk profile, which will contribute to developing more effective treatment strategies and improving the prognosis and quality of life for patients with ischemic stroke and diabetes (128, 129)
All packs are air tight sealed and expire up to 10.2029
After this initial period, the dose is increased to 5 mg weekly, with subsequent increases of 2.5 mg every 4 weeks as tolerated, up to a maximum of 15 mg weekly for diabetes management or 15 mg weekly for weight management
For fixation, 4% paraformaldehyde (PFA) was applied directly to the medium for 15 min before washing with PBS